FDA Issues Guidance on Cancer Trial Laboratory Eligibility Criteria
July 28, 2026
July 28, 2026
WASHINGTON, July 28 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has issued final guidance recommending how sponsors, institutional review boards and clinical investigators select laboratory values used as eligibility criteria for cancer clinical trials.
The guidance, "Cancer Clinical Trial Eligibility Criteria: Laboratory Values," applies to clinical trials of investigational drugs regulated by the Center for Drug Evaluation and . . .
The guidance, "Cancer Clinical Trial Eligibility Criteria: Laboratory Values," applies to clinical trials of investigational drugs regulated by the Center for Drug Evaluation and . . .